Skip to main content

ORIGINAL RESEARCH article

Front. Microbiol.
Sec. Microbial Physiology and Metabolism
Volume 15 - 2024 | doi: 10.3389/fmicb.2024.1446595

Biochemical and structural elucidation of the L-carnitine degradation pathway of the human pathogen Acinetobacter baumannii

Provisionally accepted
Fabian Piskol Fabian Piskol 1Peer Lukat Peer Lukat 2Laurin Kaufhold Laurin Kaufhold 1Alexander Heger Alexander Heger 1Wulf Blankenfeldt Wulf Blankenfeldt 2Dieter Jahn Dieter Jahn 1Jürgen Moser Jürgen Moser 1*
  • 1 Institute of Microbiology, Technical University of Braunschweig, Braunschweig, Lower Saxony, Germany
  • 2 Helmholtz Centre for Infection Research, Department Structure and Function of Proteins, Braunschweig, Germany

The final, formatted version of the article will be published soon.

    Acinetobacter baumannii is an opportunistic human pathogen which can use host-derived L-carnitine as sole carbon and energy source. Recently, an L-carnitine transporter (Aci1347) and a specific monooxygense (CntA/CntB) for the intracellular cleavage of L-carnitine have been characterized. Subsequent conversion of the resulting malic semialdehyde into the central metabolite L-malate was hypothesized. Alternatively, L-carnitine degradation via D-malate with subsequent oxidation into pyruvate was proposed. Here we describe the in vitro and in vivo reconstitution of the entire pathway, starting from the as yet uncharacterized gene products of the carnitine degradation gene operon. Using recombinantly purified enzymes, enantiomer-specific formation of D-malate by the NAD(P) +dependent malic semialdehyde dehydrogenase (MSA-DH) is demonstrated. The solved X-ray crystal structure of tetrameric MSA-DH reveals the key catalytic residues Cys 290 and Glu 256 , accessible through opposing substrate and cofactor funnels. Specific substrate binding is enabled by Arg 166 , Arg 284 and Ser 447 while dual cofactor specificity for NAD + and NADP + is mediated by Asn 184 . The subsequent conversion of the unusual D-malate reaction product by an uncharacterized NAD + -dependent malate dehydrogenase (MDH) is shown. Tetrameric MDH is a -decarboxylating dehydrogenase that synthesizes pyruvate. MDH experiments with alternative substrates showed a high degree of substrate specificity. Finally, the entire A. baumannni pathway was heterologously reconstituted, allowing E. coli to grow on L-carnitine as a carbon and energy source. Overall, the metabolic conversion of Lcarnitine via malic semialdehyde and D-malate into pyruvate, CO2 and trimethylamine was demonstrated. Trimethylamine is also an important gut microbiota-dependent metabolite that is associated with an increased risk of cardiovascular disease. The pathway reconstitution experiments allowed us to assess the TMA forming capacity of gut microbes which is related to human cardiovascular health.

    Keywords: Acinetobacter baumannii, Carnitine, Carnitine monooxygenase, Trimethylamine, malic semialdehyde dehydrogenase, D-malate dehydrogenase, X-ray crystal structure

    Received: 10 Jun 2024; Accepted: 02 Aug 2024.

    Copyright: © 2024 Piskol, Lukat, Kaufhold, Heger, Blankenfeldt, Jahn and Moser. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Jürgen Moser, Institute of Microbiology, Technical University of Braunschweig, Braunschweig, 38106, Lower Saxony, Germany

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.